Mini Nicotine 4 mg/1 (Nicotine Polacrilex LOZENGE) 4 mg/1

Mini Nicotine 4 mg/1 Lozenges are a nicotine replacement therapy designed to help manage nicotine cravings. These oral lozenges provide a controlled release of nicotine to support smoking cessation efforts.

Strength

4 mg/1

Pack Size

1 BOTTLE, PLASTIC in 1 BOX (0536-1241-27) / 27 LOZENGE in 1 BOTTLE, PLASTIC

Manufacturer / TM Owner

Rugby Laboratories, Inc.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Mini Nicotine 4 mg/1 Lozenges are used as a smoking cessation aid. They help reduce nicotine cravings and withdrawal symptoms by delivering nicotine through oral absorption. This product is intended for adults who are at least 18 years old and want to quit smoking.

Side Effects

Common effects of Mini Nicotine 4 mg/1 Lozenges may include a tingling or cooling sensation in the mouth, increased salivation, and a mild headache. Some users may experience nausea or an upset stomach, especially if the lozenge is chewed or swallowed too quickly.

Precautions & Warnings

Handle Mini Nicotine 4 mg/1 Lozenges with care, keeping them out of reach of children and pets. Store them in a cool, dry place away from direct sunlight. Do not use if you are allergic to nicotine or any of the ingredients. Consult a healthcare provider before use if you have any medical conditions or are taking other medications.

Avoid Interactions

Mini Nicotine 4 mg/1 Lozenges may interact with certain medications, including those metabolized by the liver's cytochrome P450 enzymes. Avoid using this product with other nicotine-containing products to prevent excessive nicotine intake. Alcohol consumption should be limited as it may enhance the effects of nicotine.

Frequently Asked Questions

Mini Nicotine 4 mg/1 Lozenges are used as a smoking cessation aid to help manage nicotine cravings and withdrawal symptoms.

Place the lozenge in your mouth and allow it to dissolve slowly. Do not chew or swallow the lozenge quickly to ensure proper absorption.

Common side effects may include a tingling sensation in the mouth, increased salivation, mild headache, nausea, and upset stomach.

Consult a healthcare provider before using Mini Nicotine 4 mg/1 Lozenges with other medications, as interactions may occur.

Mini Nicotine 4 mg/1 Lozenges can be purchased from authorized retailers and online pharmacies.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.